Stay updated on Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Revision indicator updated from v3.5.4 to v3.5.5, indicating a new page version. The change reflects a version update and does not alter the study details displayed.
    Difference
    0.0%
    Check dated 2026-06-05T23:50:13.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.3 to v3.5.4, signaling a minor update to the page's version rather than a substantive change to its content.
    Difference
    0.0%
    Check dated 2026-05-15T15:20:22.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page footer now shows an updated release/revision version (from v3.5.2 to v3.5.3) for the ClinicalTrials.gov interface.
    Difference
    0.0%
    Check dated 2026-04-24T06:35:47.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is now shown on the page, replacing the previous Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T02:52:05.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T05:08:29.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3; no study details or navigation were affected.
    Difference
    0.0%
    Check dated 2026-03-12T00:47:35.000Z thumbnail image

Stay in the know with updates to Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page.